A revolutionary new approach to tissue injury and repair
Avipero Ltd is a privately held start-up company established in 2009. AVIPERO is uniquely positioned in the area of integrin therapeutic as we have a proprietary, patented treatment for inducing tissue repair through a mechanism that may revolutionise the treatment of many debilitating and degenerative conditions. This treatment was discovered by Rehab AlJamal-Naylor and David Harrison in 2002. The main diseases where preclinical efficacy has been shown are Chronic Obstructive Pulmonary Disease (COPD), Parkinson’s disease and arthritis.
Our new therapeutic could revolutionalise the treatment of these indications alone or in combination with othe more